Page last updated: 2024-09-03

zk 112993 and Adenocarcinoma

zk 112993 has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gurpide, E; Markiewicz, L	1

Other Studies

1 other study(ies) available for zk 112993 and Adenocarcinoma

Article	Year
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays. Methods and findings in experimental and clinical pharmacology, 1997, Volume: 19, Issue:4 Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured	1997

Article

Year

Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.

Methods and findings in experimental and clinical pharmacology, 1997, Volume: 19, Issue:4

Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured

1997